German Pharmaceuticals & Biotech Potentially Undervalued Companies

Spectrum Pharmaceuticals

Market Cap: €209.9m

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products.

Green Thumb Industries

Market Cap: €2.1b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Perrigo

Market Cap: €1.8b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

UCB

Market Cap: €43.1b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Grand Pharmaceutical Group

Market Cap: €18.4b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Indivior Pharmaceuticals

Market Cap: €4.5b

Engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Prestige Consumer Healthcare

Market Cap: €2.5b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

United Therapeutics

Market Cap: €22.7b

Engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Bavarian Nordic

Market Cap: €13.5b

Develops, manufactures, and supplies life-saving vaccines.

UCB

Market Cap: €43.1b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

United Laboratories International Holdings

Market Cap: €17.9b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

Virbac

Market Cap: €2.8b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.

Trajan Group Holdings

Market Cap: €30.5m

Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.

ANI Pharmaceuticals

Market Cap: €1.6b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

China Resources Pharmaceutical Group

Market Cap: €30.8b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

Cresco Labs

Market Cap: €465.8m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

Bausch Health Companies

Market Cap: €2.4b

Operates as a diversified specialty pharmaceutical and medical device company.

China Medical System Holdings

Market Cap: €29.1b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

Consun Pharmaceutical Group

Market Cap: €11.8b

Produces and sells pharmaceutical products in Mainland China.

Laboratorios Farmaceuticos Rovi

Market Cap: €3.0b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Dermapharm Holding

Market Cap: €2.0b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

CorMedix

Market Cap: €590.7m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

High Tide

Market Cap: €283.8m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Bavarian Nordic

Market Cap: €13.5b

Develops, manufactures, and supplies life-saving vaccines.

Vetoquinol

Market Cap: €834.5m

A veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.

Dermapharm Holding

Market Cap: €2.0b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

Goodbody Health

Market Cap: €1.3m

Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom.

Gossamer Bio

Market Cap: €86.1m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States.

GSK

Market Cap: €76.0b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Fortrea Holdings

Market Cap: €1.8b

A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

Novo Nordisk

Market Cap: €1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

argenx

Market Cap: €46.8b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Viatris

Market Cap: €18.7b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

ACADIA Pharmaceuticals

Market Cap: €5.1b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

Viatris

Market Cap: €18.7b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Bristol-Myers Squibb

Market Cap: €132.4b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.